Just-In-time Adaptive Intervention (JITAI) for Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
The University of Michigan, Ann Arbor, MI
Hypertension+1 More
Just-In-time Adaptive Intervention (JITAI) - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This research is being done to learn if a smartphone app with and without a just in time adaptive intervention (JITAI) can help patients with hypertension manage their sodium intake and improve their blood pressure.

Eligible Conditions

  • Blood Pressures
  • Hypertension

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 2 months

2 months
Percent of participants at a goal blood pressure (BP)
Baseline, 2 months
Change in dietary nutrient intake
Change in estimated sodium intake
Change in systolic blood pressure (SBP)
Change in weight over 2 months
Changes in blood pressure (BP) medications

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension

Trial Design

2 Treatment Groups

LowSalt4Life
1 of 2
LowSalt4Life + just-in-time adaptive intervention (JITAI)
1 of 2
Active Control
Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: Just-In-time Adaptive Intervention (JITAI) · No Placebo Group · N/A

LowSalt4Life + just-in-time adaptive intervention (JITAI)Experimental Group · 2 Interventions: Just-In-time Adaptive Intervention (JITAI), LowSalt4Life Application · Intervention Types: Behavioral, Behavioral
LowSalt4Life
Behavioral
ActiveComparator Group · 1 Intervention: LowSalt4Life Application · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 months
Closest Location: The University of Michigan · Ann Arbor, MI
Photo of ann arbor 1Photo of ann arbor 2Photo of ann arbor 3
2010First Recorded Clinical Trial
2 TrialsResearching Hypertension
38 CompletedClinical Trials

Who is running the clinical trial?

University of MichiganLead Sponsor
1,597 Previous Clinical Trials
6,328,657 Total Patients Enrolled
33 Trials studying Hypertension
7,932 Patients Enrolled for Hypertension
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,555 Previous Clinical Trials
46,914,789 Total Patients Enrolled
438 Trials studying Hypertension
2,068,936 Patients Enrolled for Hypertension
Brahmajee NallamothuPrincipal InvestigatorUniversity of Michigan

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a smartphone with a compatible Apple or Android operating system installed and are willing to allow the LowSalt4Life app to send push notifications.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.